Esobiz Tablet contains Esomeprazole 40 mg, a proton pump inhibitor (PPI) used primarily to reduce gastric acid secretion. It is indicated for the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, Zollinger-Ellison syndrome, and other conditions associated with excessive stomach acid production. Esomeprazole acts by irreversibly inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, thereby suppressing the final step of acid production. This leads to a significant reduction in gastric acidity, promoting healing of acid-related damage and alleviating symptoms such as heartburn, acid regurgitation, and gastric discomfort. Esobiz Tablet is typically administered orally once daily, preferably before meals, with the dosage and duration tailored according to the clinical condition and patient response. It is generally well tolerated; however, potential adverse effects may include headache, diarrhea, nausea, abdominal pain, and dizziness. Long-term use should be monitored due to risks such as vitamin B12 deficiency, hypomagnesemia, and increased susceptibility to gastrointestinal infections. Esobiz Tablet should be used with caution in patients with hepatic impairment and is contraindicated in individuals with known hypersensitivity to esomeprazole or other PPIs. Consultation with a healthcare professional is recommended before initiating therapy.